North America Cardiac Markers Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Cardiac Markers Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Cardiac Markers Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Prevalence of Cardiovascular Diseases create demnad for cardiac markers

5.2 Market Opportunities

5.2.1 Investments in Cardiovascular Sector leds to new product developments and launch create ample opportunities

5.3 Future Trends

5.3.1 Surge in Demand for Point-of-Care Cardiac Testing Kits favors Market Growth

5.4 Impact of Drivers and Restraints

6. North America Cardiac Markers Market Regional Analysis

6.1 North America Cardiac Markers Market Overview

6.2 North America Cardiac Markers Market Revenue 2021-2031 (US$ Billion)

6.3 North America Cardiac Markers Market Forecast Analysis

7. North America Cardiac Markers Market Analysis – by Product Type

7.1 Reagents and Kits

7.1.1 Overview
7.1.2 Reagents and Kits: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

7.2 Analyzers

7.2.1 Overview
7.2.2 Analyzers: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

8. North America Cardiac Markers Market Analysis – by Biomarker Type

8.1 Troponin

8.1.1 Overview
8.1.2 Troponin: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

8.2 Creatine Kinase-MB

8.2.1 Overview
8.2.2 Creatine Kinase-MB: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

8.3 Myoglobin

8.3.1 Overview
8.3.2 Myoglobin: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

8.4 B-Type Natriuretic Peptide

8.4.1 Overview
8.4.2 B-Type Natriuretic Peptide: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

9. North America Cardiac Markers Market Analysis – by Indication

9.1 Congestive Heart Failure

9.1.1 Overview
9.1.2 B-Type Natriuretic Peptide: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

9.2 Myocradial Infraction

9.2.1 Overview
9.2.2 B-Type Natriuretic Peptide: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

9.3 Acute Coronary Syndrome

9.3.1 Overview
9.3.2 B-Type Natriuretic Peptide: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

10. North America Cardiac Markers Market – North America Analysis

10.1 North America

10.1.1 North America Cardiac Markers Market Breakdown, by Key Country, 2024 and 2031 (%)
10.1.1.1 North America Cardiac Markers Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

10.1.1.1.1 US: North America Cardiac Markers Market Breakdown, by Product Type
10.1.1.1.2 US: North America Cardiac Markers Market Breakdown, by Biomarker Type
10.1.1.1.3 US: North America Cardiac Markers Market Breakdown, by Indication

10.1.1.2 Canada: North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

10.1.1.2.1 Canada: North America Cardiac Markers Market Breakdown, by Product Type
10.1.1.2.2 Canada: North America Cardiac Markers Market Breakdown, by Biomarker Type
10.1.1.2.3 Canada: North America Cardiac Markers Market Breakdown, by Indication

10.1.1.3 Mexico : North America Cardiac Markers Market – Revenue and Forecast to 2031 (US$ Billion)

10.1.1.3.1 Mexico : North America Cardiac Markers Market Breakdown, by Product Type
10.1.1.3.2 Mexico : North America Cardiac Markers Market Breakdown, by Biomarker Type
10.1.1.3.3 Mexico : North America Cardiac Markers Market Breakdown, by Indication

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Cardiac Markers Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Beckman Coulter Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Creative Diagnostics

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Bio-Rad Laboratories Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Diazyme Laboratories Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 bioMerieux SA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 HyTest Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 QuidelOrtho Corp

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Thermo Fisher Scientific Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 F. Hoffmann-La Roche Ltd

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights